Prevalence of herpes simplex virus-1 in hospitalized adult patients with clinical diagnosis of meningoencephalitis using real-time polymerase chain reaction: A single-center, cross-sectional study.

Cerebrospinal fluid herpes simplex virus meningoencephalitis polymerase chain reaction

Journal

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
ISSN: 1735-1995
Titre abrégé: J Res Med Sci
Pays: India
ID NLM: 101235599

Informations de publication

Date de publication:
2019
Historique:
received: 27 08 2017
revised: 07 03 2018
accepted: 22 10 2018
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 1 3 2019
Statut: epublish

Résumé

Early diagnosis of herpes simplex virus-1 (HSV-1) meningoencephalitis is very important because antiviral therapy significantly decreases mortality and morbidity. Polymerase chain reaction (PCR) is a reliable method with high sensitivity and specificity in detection of HSV-1. The aim of this study is to determine the prevalence of HSV-1 in patients with diagnosis of meningoencephalitis using real-time PCR. The cerebrospinal fluid samples were collected from 126 patients with clinical diagnosis of HSV-1 meningoencephalitis in Alzahra Referral Hospital in Isfahan, Iran. After deoxyribonucleic acid (DNA) extraction, real-time PCR was performed by fluorescence resonance energy transfer assay and participants underwent brain magnetic resonance imaging, as well. Among 126 patients, 68.3% were male and 31.7% were female. The mean age of the participants was 41.96 ± 22.36 years. Most of the participants were in the age group of 20-29 years. Three patients (2.4%) had positive and 123 patients (97.6%) had negative HSV-1 DNA test. Among three positive cases, two were in the age group of 20-29 years and one in the age group of ≥80 years. No HSV-2 DNA was detected. According to the estimated prevalence of HSV-1 meningoencephalitis in the current study, it seems that the prevalence of HSV-1 meningoencephalitis is not too high in our community; therefore, initial empiric acyclovir therapy is frequently overused.

Sections du résumé

BACKGROUND BACKGROUND
Early diagnosis of herpes simplex virus-1 (HSV-1) meningoencephalitis is very important because antiviral therapy significantly decreases mortality and morbidity. Polymerase chain reaction (PCR) is a reliable method with high sensitivity and specificity in detection of HSV-1. The aim of this study is to determine the prevalence of HSV-1 in patients with diagnosis of meningoencephalitis using real-time PCR.
MATERIALS AND METHODS METHODS
The cerebrospinal fluid samples were collected from 126 patients with clinical diagnosis of HSV-1 meningoencephalitis in Alzahra Referral Hospital in Isfahan, Iran. After deoxyribonucleic acid (DNA) extraction, real-time PCR was performed by fluorescence resonance energy transfer assay and participants underwent brain magnetic resonance imaging, as well.
RESULTS RESULTS
Among 126 patients, 68.3% were male and 31.7% were female. The mean age of the participants was 41.96 ± 22.36 years. Most of the participants were in the age group of 20-29 years. Three patients (2.4%) had positive and 123 patients (97.6%) had negative HSV-1 DNA test. Among three positive cases, two were in the age group of 20-29 years and one in the age group of ≥80 years. No HSV-2 DNA was detected.
CONCLUSION CONCLUSIONS
According to the estimated prevalence of HSV-1 meningoencephalitis in the current study, it seems that the prevalence of HSV-1 meningoencephalitis is not too high in our community; therefore, initial empiric acyclovir therapy is frequently overused.

Identifiants

pubmed: 30815020
doi: 10.4103/jrms.JRMS_370_17
pii: JRMS-24-7
pmc: PMC6383335
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Pediatr Rev. 1999 Jun;20(6):192-8
pubmed: 10352040
J Clin Virol. 2000 Jun;17(1):31-6
pubmed: 10814936
Neurol India. 2003 Sep;51(3):341-4
pubmed: 14652434
J Clin Virol. 2005 Apr;32(4):318-24
pubmed: 15780812
Rev Neurol Dis. 2004 Fall;1(4):169-78
pubmed: 16400278
Braz J Infect Dis. 2011 May-Jun;15(3):211-4
pubmed: 21670919
Indian J Tuberc. 2013 Jan;60(1):5-14
pubmed: 23540083
J Neurol. 1994 Aug;241(9):526-30
pubmed: 7799000
Lancet. 1997 Feb 1;349(9048):313-7
pubmed: 9024374
J Neurol Sci. 1998 May 7;157(2):148-53
pubmed: 9619637
J Clin Microbiol. 1998 Aug;36(8):2229-34
pubmed: 9665997

Auteurs

Kiana Shirani (K)

Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Farzin Khorvash (F)

Nosocomial Infections Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Alireza Emami Naeini (AE)

Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Majid Valiyan Boroujeni (M)

Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Mohammadreza Yazdani (M)

Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Classifications MeSH